Minimum fixation angle prevents postoperative pIOL rotation

Article

Toric phakic intraocular lens (pIOL) intraoperative fixation angle should be kept to a minimum to avoid postoperative rotation.

Toric phakic intraocular lens (pIOL) intraoperative fixation angle should be kept to a minimum to avoid postoperative rotation, claims a study in the Journal of Cataract and Refractive Surgery.

Dr Takashi Kjima et al., Nagoya Eye Clinic, Nagoya, Japan, conducted a case series on 34 patients implanted with a toric implantable collamer pIOL. The pIOL axis was recorded by calculating ocular internal cylinder power and the axis using the total refractive cylinder and corneal astigmatism using vector analysis.

Preoperative manifest refractive sphere, preoperative manifest spherical equivalent, mean keratometric power, axial length, toric pIOL intraoperative fixation angle, postoperative toric pIOL vault and toric spherical power were among the potential factors that were associated with toric pIOL rotation. They were all correlated with toric pIOL rotation over six months postoperatively.

Postoperative toric pIOL rotation and intraoperative toric pIOL fixation angle were strongly correlated. Mean rotation six months postoperatively was 4.82 ± 6.98 degrees. The toric pIOL was swapped for a larger toric pIOL in one eye with significant pIOL rotation.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.